Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
soco
on July 16, 2024
|
parent
|
context
|
favorite
| on:
The Mafia of Pharma Pricing
Maybe it depends who you want to benefit with your regulation - the patient or the provider? Because I'd argue providers seem to make good money within the US regulation.
shiroiushi
on July 16, 2024
[–]
I'm not so sure about that actually. I think the real winner in the US system is the insurance companies.
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search: